Skip to main content
Log in

Androgen metabolites in blood of patients with prostatic carcinoma

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Dehydroepiandrosterone, androsterone and etiocholanolone sulphate esters have been determined in peripheral blood plasma of patients with prostatic carcinoma. A significant decrease in the plasma level of steroid was observed. A diminution in the excretion rate of certain 17-oxosteroid conjugates was also found in the same patients. There was no correlation between the steroid levels and orchidectomy or heterosexual hormone treatment.

From the findings it is assumed that an insufficient production of dehydroepiandrosterone and/or its sulphate ester in adrenal may play a role in the low steroid content of peripheral blood and urine. However, the abnormality of steroid metabolism appears to be in no close relationship with the disease, rather, it may be the consequence of an aspecific stress reaction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Acevedo, F. H., Goldzieher, W. J.: The metabolism of (4-14C)-androstene-3,17-dione by normal human prostatic tissue.Biochem. biophys. Acta 82, 118 (1964).

    Google Scholar 

  2. Baulieu, E. E., Corpéchot, C., Dray, F., Emiliozzi, R., Lebeau, M. C., Mauvais-Jarvis, P., Robel, P.: An adrenal-secreted “androgen”: Dehydroepiandrosterone sulphate. Its metabolism and a tentative generalization on the metabolism of other steroid conjugates in man.Recent Progr. Hormone Res. 21, 411 (1965).

    PubMed  Google Scholar 

  3. Bénard, H., Bourdin, J. S., Saracino, R., Seeman, A.: Etude des 17-cétostéroides plasmatiques totaux et des 17-hydroxy-corticostéroides plasmatiques libres chez des hommes atteits de cancer de la prostate ou du testicule.C. R. Acad. Sc. Paris266, 604 (1968).

    Google Scholar 

  4. Bénard, H., Seeman, A.: A propos du dosage des 17-cétostéroides plasmatiques.Bull. Soc. Chim. biol. 45, 1405 (1963).

    PubMed  Google Scholar 

  5. Farnsworth, E. W.: 10-Demethylation of testosterone by human prostate,in vitro.Steroids 6, 519 (1965).

    PubMed  Google Scholar 

  6. Farnsworth, E. W., Brown, J. R.: Metabolism of testosterone by the human prostate.J. Amer. med. Ass. 183, 140 (1963).

    Google Scholar 

  7. Fehér, T.: Some aspects of the determination of individual urinary 17-oxosteroids: Methodology.Clin. chim. Acta 14, 83 (1966).

    PubMed  Google Scholar 

  8. Fehér, T.: Some aspects of the determination of individual urinary 17-oxosteroids: Normal excretion.Clin. chim. Acta 14, 91 (1966).

    PubMed  Google Scholar 

  9. Fehér, T., Koref, O., Kazik, H. M.: Simultanbestimmung von freiem Cortisol, esterifizierten Dehydroepiandrosteron und Androsteron im peripheren Blut.Acta endocr. 51, 429 (1966).

    PubMed  Google Scholar 

  10. Fehér, T., Koref, O., Csellár, M., Szendrői, Z.: Prostatarákos betegek vizeletének steroidanyagcsere termékei.Magy. Belorv. Arch. 18, 159 (1965).

    Google Scholar 

  11. Gallagher, T. F., Whitmore, F. W., Zumoff, B., Hellman, L.: Steroid hormone metabolites before and after orchidectomy for prostatic cancer.J. clin. Endocr. 23, 523 (1963).

    PubMed  Google Scholar 

  12. Gandy, M. H., Peterson, E. R.: Measurement of testosterone and 17-ketosteroids in plasma by the double isotope dilution derivative technique.J. clin. Endocr. 28, 949 (1968).

    PubMed  Google Scholar 

  13. Isurugi, K.: Plasma testosterone production rates in patients with prostatic cancer and benign prostatic hypertrophy.J. Urol., 97, 903 (1967).

    PubMed  Google Scholar 

  14. Kent, J. R., Young, H. H.: Plasma testosterone levels in patients with prostatic carcinoma.Surg. Forum 15, 485 (1964).

    PubMed  Google Scholar 

  15. Pearlman, W. H., Pearlman, M. R.: The metabolism in vivo of 4-androstene-3,17-dione-7-H3: its localisation in the ventral prostate and other tissues of the rat.J. biol. Chem. 236, 1321 (1961).

    PubMed  Google Scholar 

  16. Segaloff, A.: The enhanced local androgenic activity of 19-nor steroids and stabilization of their structure by 7α- and 17α-methyl substituents to highly potent androgens by any route of administration.Steroids 1, 299 (1963).

    Google Scholar 

  17. Shimazaki, J., Kurihara, H., Ito, Y., Shida, K.: Testosterone metabolism in prostate; formation of androstan-17β-ol-3-one and androst-4-ene-3,17-dione, and inhibitory effect of natural and synthetic estrogens.Gunma J. Med. Sci., 14, 313 (1965).

    PubMed  Google Scholar 

  18. Szendrői, Z., Koref, O., Fehér, T., Csellár, M.: Über die Ausscheidung der Steroidstoffwechsel-Produkte im Harn bei Prostatakrebs.Arch. Geschwulstforsch. 26, 18 (1965).

    Google Scholar 

  19. Tamm, J.: Der Testosteronstoffwechsel beim Menschen.Med. Wschr. 92, 1983, 2037, 2080 (1967).

    Google Scholar 

  20. Vihko, R.: Gas chromatographic-mass spectrometric studies on solvolyzable steroids in human peripheral plasma.Acta endocr. Suppl. 109 (1966).

  21. Young, H. H., Kent, J. R.: Plasma testosterone levels in patients with prostatic carcinoma before and after treatment.J. Urol. 99, 788 (1968).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fehér, T., Koref, O., Szendrői, Z. et al. Androgen metabolites in blood of patients with prostatic carcinoma. International Urology and Nephrology 2, 163–169 (1970). https://doi.org/10.1007/BF02125817

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02125817

Keywords

Navigation